Previous 10 | Next 10 |
The shares for Doximity (NYSE: DOCS) , Iqvia Holdings (NYSE: IQV) , and TransMedics Group (NASDAQ: TMDX) are all off to positive starts this year, but what makes them different from other companies is that they are changing healthcare industry standards. Doximity i...
Shares of Doximity (NYSE: DOCS) rose 13.5% this week as of Thursday's close, according to data provided by S&P Global Market Intelligence . The stock closed last Friday at $34.95 and rose to as high as $40.12 on Thursday afternoon, the highest the stock has been since last Aug. 2....
Summary With 2022 in the books, it's time for my annual review of my portfolio and its performance. This was the first down year for the broad market since I began tracking my portfolio on Seeking Alpha. My portfolio held up well during the downturn, and I have begun to re-position ...
Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Mid Cap Growth Strategy targets attractively pr...
As hundreds of growth stocks sold off amid rising interest rates and a tumultuous market in 2022, even strong operators were caught up in this drop's wake. This divergence between shorter-term movements, which are tied to quarterly earnings concerns versus a company's longer-term prospects, often...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2022 after market close on February 9, 2023. Doximity will host a conference call and webcast at 2:00 p.m. PT (...
Medpace Holdings (NASDAQ: MEDP) and Doximity (NYSE: DOCS) hold unique spots in the healthcare industry, with Medpace being a Top-10 clinical contract research organization (CRO) and Doximity being the best way for advertisers to reach physicians. Both companies have sound fi...
If you're looking for stocks that can deliver explosive gains, the healthcare sector has you covered, Doximity (NYSE: DOCS) , TransMedics (NASDAQ: TMDX) , and InMode (NASDAQ: INMD) are leading the niche markets where they earn a living, but the stock market doesn't seem to...
Healthcare networking platform Doximity (NYSE: DOCS) went public in late 2021. The stock nearly doubled just months later, but has since cooled off in this bear market. The stock is down 68% from its high, more than giving back those quick post-IPO gains. Is the stock destined to rebound ...
Summary Doximity is a rare IT vendor who reported positive business trends when it released its Q3 results at the start of November, 2022. The company's big pharma and hospital customers showed increased appetite for Doximity solutions. The company is one of the most profitable IT v...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...